Esta é uma pré-visualização de arquivo. Entre para ver o arquivo original
Neurofunctional Techniques Lessons 9/10/12 16 October 2023 17 October 2023 23 October 2023 Viral delivery methods Optogenetics X-genetics Calendar • M 25 Sept: Course introduction • T 26 Sept: Functional imaging • W 27 Sept: Functional imaging • M 2 Oct: Biophysics of diffusion • T 3 Oct: Functional imaging • W 4 Oct: Practical exercise: paper presentations • M 9 Oct: Modeling in neuroscience + Exercises on the first part of the course • T 10 Oct: Exercises on the first part of the course • W 11 Oct: Statistics (Cesca) • M 16 Oct: Molecular approaches in modern neuroscience • T 17 Oct: Optogenetics • W 18 Oct: Practical exercise: paper discussion • M 23 Oct: X-genetics + Exercises on the second part of the course • T 24 Oct: Practical exercise: paper discussion • W 25 Oct: Statistics (Cesca) • M 30 Oct: Practical exercise: paper discussion • T 7 Nov: Genome editing in neuroscience (Dr. Jaudon) • M 20 Nov: In vivo Ca2+ imaging (Dr. Riccardi) • W 15 Nov: Statistics (Cesca) • T 28 Nov: Seminar Francesco Papaleo (IIT, Genova) • W 29 Nov: Statistics (Cesca) • M 4 Dic: Questionnaire (date to be confirmed) • 11, 12, 13, 14, 18, 19 Dic: Presentation paper Objectives 1. Introduce most commonly used viral delivery systems 2. Being able to chose the most appropriate one for a specific experimental purpose Lentiviruses vs. recombinant adeno-associated viruses (rAAVs) Infection localized with lenti Broader with rAAVs Lenti better for primary cultures rAAV (vs. lentivirus) properties Inverted Terminal Repeat • Size: 1 hr/animal) 2) Intracerebroventricular injections in pups Technically similar to in utero electroporation Intracerebroventricular injections in pups can be combined with Intersectional expression Intra- cerebral injection P0 Dual AAV system Increased expression in cortical neurons Rescue of behavioural phenotype EGFP dCas9-VP64 gRNA gRNA tdTomatoF/+; CaMKII-Cre/+ 3) Systemic delivery 3) Systemic delivery Chan et al., 2017 3) Systemic delivery Chan et al., 2017 Tremendous potential for gene therapy Anterograde - retrograde labeling rAAV2-retro Retrograde labeling of projection neurons with rAAV2-retro Retrograde labeling of projection neurons with rAAV2-retro Tervo et al., 2016 rAAV2-retro to distinguish cortical pyramidal neurons based on their projection sites Intratelencephalic (IT) neurons contralateral cortex Pyramidal tract (PT) neurons outside of the cortex Layer V Bsn rAAV2-retro to distinguish cortical pyramidal neurons based on their projection sites Injection in the Pons PT neurons Injection in the contro-lateral cortex IT neurons Retrograde AAV-mediated EGFP labeling Intratelencephalic (IT) neurons Pyramidal tract (PT) neurons Layer V Bsn rAAV2-retro identifies neuron type- and genotype- specific differences in dendritic spine morphology Celora et al., 2023 PT IT β 3 in te gr in Tervo et al., 2016 rAAV2-retro to distinguish cortical projection neurons: activity Tervo et al., 2016 rAAV2-retro to distinguish cortical projection neurons: rescue experiments Anterograde - retrograde labeling rAAV2-retro Monosynaptic retrograde labelling • It requires recombinant rabies viruses (RABVs) • In contrast to non-viral tracers, trans-synaptic viral labeling is amplified rather than diluted. This occurs thanks to the replicative nature of viruses • The CVS derived strains of RABVs spread exclusively in a synapse-specific manner; (other polysynaptic viral tracers do not spread exclusively at synaptic sites and label neurons that are not necessarily connected by synapses) • RABVs spreads retrogradely (from the post- to pre-synaptic neuron) • Other advantages of RABVs: reduced cytotoxicity and the possibility to use them in primates • Native RABVs are polysynaptic tracers, causing ambiguity in the interpretation of how many synaptic steps have been crossed at any given time • RABVs are negative-sense single-stranded RNA viruses, making impossible the use of useful genetic tools, such as lox P sites, tet-regulatory sequences or cell-specific promoters Retrograde labeling rAAV2-retro Monosynaptic retrograde labelling Production of recombinant RABVs with either: • native glycoprotein or • a different glycoprotein (EnvA) Native glycoprotein: monosynaptic but not neuron-type specific Native glycoprotein Monosynaptic retrograde labelling Production of recombinant RABVs with either: • native glycoprotein or • a different glycoprotein (EnvA) EnvA EnvA: monosynaptic and neuron-type specific Monosynaptic retrograde labelling CA1 subiculum Cre-dependent helper rAAV expressing the TVA receptor + EGFP + the glycoprotein EnvA(G) are injected in the subiculum Use of transgenic mouse expressing Cre in the subiculum thanks to the fibronectin promoter One week later, recombinant RABVs coated with EnvA(G) and expressing mCherry are injected in the subiculum Conclusions - viruses 1. From an experimental point of view consider: a. Promoter type b. Serotype type c. Delivery method 2. Tremendous potential for therapeutic applications in brain disorders (e.g. BBB-permeable injectable rAAVs) 3. Retrograde labelling for neuronal connectivity a. rAAV2-retro b. RABVs Objectives 1. Appreciate the power of X-genetics 2. Introduce the most commonly X-genetic systems X-genetics • Optogenetics: introduction • Cellular precision • Opsin types • Light delivery systems • Examples of optical interrogation of neural circuits • Other uses of optogenetics • Non-opotogentics - Chemogenetics - Magnetogenetics X-genetics • Optogenetics: introduction • Cellular precision • Opsin types • Light delivery systems • Examples of optical interrogation of neural circuits • Other uses of optogenetics • Non-opotogentics - Chemogenetics - Magnetogenetics Why we need optogenetics In describing unrealized prerequisites for assembling a general theory of the mind, Francis Crick underlined the need of ‘a method by which all neurons of just one type could be inactivated, leaving the others more or less unaltered’ (Crick 1979). Optogenetics: Combining genetics and optics to achieve loss- or gain-of- function of well-defined neuronal circuits with high temporal precision. Why we need optogenetics Conceptually similar to knock out/down and over-expression experiments but the aim is to silence or activate neuronal populations rather than genes Optogenetics : the basic priniples Channelrhodopsin: An ion channel activated by light Optogenetics to study neural circuits of behavior Advantages of optogenetics 1) Advantages over electrophysiology: High cellular precision, mainly because of the ‘genetics’ part 2) Advantages over pharmacology: High temporal precision, mainly because of the ‘optics’ part Traditionally, we could study the neural bases of behavior by combining electrophysiological methods and pharmacology X-genetics • Optogenetics: introduction • Cellular precision • Opsin types • Light delivery systems • Examples of optical interrogation of neural circuits • Other uses of optogenetics • Non-opotogentics - Chemogenetics - Magnetogenetics Targeting strategies for optogenetics Site-directed intracranial injections Site-directed intracranial injections + light delivery Site-directed intracranial injections + cell-type specific promoter or Cre- dependent expression Targeting strategies for optogenetics Site-directed intracranial injections + Cre in rAAV2-retro Site-directed intracranial injections + cell-type specific promoter or Cre- dependent expression + wavelength Site-directed intracranial injections + cell-type specific promoter or Cre- dependent expression + wavelength Advantages of optogenetics 1) Advantages over electrophysiology: High cellular precision, mainly because of the ‘genetics’ part 2) Advantages over pharmacology: High temporal precision, mainly because of the ‘optics’ part Traditionally, we could study the neural bases of behavior by combining electrophysiological methods and pharmacology X-genetics • Optogenetics: introduction • Cellular precision • Opsin types • Light delivery systems • Examples of optical interrogation of neural circuits • Other uses of optogenetics • Non-opotogentics - Chemogenetics - Magnetogenetics Opsins Opsins: seven-transmembrane proteins that are light-sensitive thanks to the chromophore retinal, a vitamin A-related organic cofactor. Retinal + opsin = rhodopsin Upon absorption of a photon, retinal isomerizes and triggers a sequence of conformational changes within the opsin partner, which mediate phototransduction. There are two distant families of opsins • Type II: G-protein coupled receptors (GPCRs) found in higher eukaryotes, responsible for vision (but also circadian rhythm and pigment regulation). In the dark, type II opsins bind retinal in the 11-cis configuration. Upon illumination, retinal isomerizes to the all-trans configuration and initiates the second messenger cascade of phototransduction. After photoisomerization, the retinal-protein linkage is hydrolyzed; all-trans retinal diffuses out of the protein and is replaced by a fresh 11-cis retinal molecule for another round of signaling. • Type I: broad family of seven-transmembrane proteins found in prokaryotes, algae and fungi. They are not G-protein coupled receptors (GPCRs), rather they combine the two tasks of light sensation and ion flux into a single protein (with bound retinal), encoded by a single gene. There are two distant families of opsins They use retinal in the all-trans configuration, which photoisomerizes upon photon absorption to the 13-cis configuration. Unlike the situation with type II rhodopsins, the activated retinal molecule in type I rhodopsins does not dissociate from its opsin protein but thermally reverts to the all-trans state while maintaining a covalent bond to its protein partner. Major opsin types Cation-permeable channels for membrane depolarization (such as channelrhodopsins (ChRs)) ChR2 Chloride pumps (e.g, halorhodopsin (NpHR)) and proton pumps (such as bacteriorhodopsin or proteorhodopsin (BR/PR)) for membrane hyperpolarization Light-activated membrane-bound G protein-coupled (OptoXR) receptors for activation of signaling pathways Opsin diversification / optimization • Large & non-inactivating currents: To elicit effectively and consistently APs with minimal light stimulation • Optimization of kinetic properties: Either fast deactivation, to elicit APs that are time-locked to the light pulses Or very slow deactivation (bi-stable opsins), to change spiking propensity over defined time periods • Diversification/optimization of spectral prosperities For multiple independent optical stimulations For concomitant imaging readout Opsin diversification / optimization Point mutation for larger photocurrent Chimera ChR1/2 + point mutations for reduced inactivation Genomic identification of red-shifted opsins Chimera VChR1/ChR1 for Larger photocurrent Point mutations for faster deactivation Point mutations for faster deactivation First opsin Spectral diversification of opsins Klapoetke al., 2014 Far red Green Blue Spectral diversification Improved Kinetics for eliciting APs at high frequency Klapoetke al., 2014 Bistable opsins Step-function opsins (SFOs)/bistable opsins have mutations that stabilize the active retinal isomer, thereby prolonging the active state of the channel even after light is off. Some SFOs can also be deactivated by a pulse of yellow light; the yellow pulse drives isomerization of retinal back to the non-conducting state. Bistable opsins Berndt al., 2009 Opsin diversification / optimization X-genetics • Optogenetics: introduction • Cellular precision • Opsin types • Light delivery systems • Examples of optical interrogation of neural circuits • Other uses of optogenetics • Non-opotogentics - Chemogenetics - Magnetogenetics Light sources • Intensity of light (few mW/mm2) • Frequency of stimulation (few ms) • Hologen/xenon arc lamps • Light emitting diodes (LEDs) • Lasers Wide-field vs. cellular resolution optogenetics Light sources in vitro (b) LED- or a laser-coupled fiber placed near the brain slice. (c) Arc lamp, LED, or laser as a light source through the microscope objective (d) Digital mirror device (dMd) to illuminate specific pixels within the field of view simultaneously. Cellular-resolution optogenetics. (e) Laser scanning photostimulation (LSPS) where the laser beam is focused to a small point. LSPS illuminates with higher intensity. Unlike dMds, LSPS cannot simultaneously illuminate multiple regions of interest, but with sufficiently fast galvanometric mirrors, multiple regions can be illuminated with submillisecond delays. Cellular-resolution optogenetics. Wide-field optogenetics Laser scanning photostimulation vs Digital mirror device Laser scanning photostimulation to map the subcellular organization of neocortical excitatory connections Petreanu al., 2009 How do you get light deep into the brain tissue for in vivo experiments ? Optical fibers Only neurons that are both in the cone of illumination and express ChR2 will be activated to fire action potentials. Optogentics for Parkinson Dopamine depletion in the basal ganglia leads to altered activity of the subthalamic nucleus (STN), which has been linked to clinical deficits in movement. Electrical high-frequency (>90 Hz) stimulation (HFS) of the STN (deep brain stimulation or DBS) is a highly effective treatment for medically refractory Parkinson. But why? This highlights the importance of (i) cell-type specificity and (ii) temporal precision Gradinaru al., 2009 X-genetics • Optogenetics: introduction • Cellular precision • Opsin types • Light delivery systems • Examples of optical interrogation of neural circuits • Other uses of optogenetics • Non-opotogentics - Chemogenetics - Magnetogenetics Major opsin types Cation-permeable channels for membrane depolarization (such as channelrhodopsins (ChRs)) ChR2 Chloride pumps (e.g, halorhodopsin (NpHR)) and proton pumps (such as bacteriorhodopsin or proteorhodopsin (BR/PR)) for membrane hyperpolarization Light-activated membrane-bound G protein-coupled (OptoXR) receptors for activation of signaling pathways They change the propensity for AP firing They regulate signaling pathways Major opsin types Light-activated membrane-bound G protein-coupled (OptoXR) receptors for activation of signaling pathways They regulate signaling pathways LOV protein-based tools LOV domains are photosensory modules found in photoreceptors from plants, bacteria, fungi and algae. Upon blue light absorption, the flavin mononucleotide (FMN) cofactor forms a transient covalent bond with a cysteine residue, resulting in a conformational change. This process reverts in the dark over the course of seconds to minutes via hydrolysis of the FMN–cysteine bond. In optogenetics, LOV domains coupled to non- endogenous effector proteins enable blue light- mediated modulation of protein accessibility and activity. Gene expression Enzyme activity Membrane recruitment LOV protein-based tools LOV2 LOV2 Conclusions - optogenetics 1. Optogenetics allows for loss- or gain-of-function of well-defined neuronal circuits with high temporal precision 2. Types: a. for membrane depolarization (ChR2) b. for membrane hyperpolarization (NpHR) c. for activation of signaling pathways (OptoXR) receptors 3. Optimizations/diversifications: a. Large non-inactivating currents (ChR2; H134R) b. Fast kinetic properties (Chronos) c. Spectral properities (Chrimson) d. Step-function opsins (SFOs)/bistable opsins 4. Light delivery systems: a. Wide-field b. cellular resolution optogenetics 5. LOV protein-based tools X-genetics • Optogenetics: introduction • Cellular precision • Opsin types • Light delivery systems • Examples of optical interrogation of neural circuits • Other uses of optogenetics • Non-opotogentics - Chemogenetics - Magnetogenetics Chemogenetics Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) Gq Gs Gi Gi Gi Not as invasive as optogenetics Slower than optogentics Metabotropic receptorsMetabotropic receptors Metabotropic receptor Gq/11 protein Metabotropic receptorsMetabotropic receptors Gs protein Metabotropic receptor Metabotropic receptorAdenylyl cyclase PKA / EPAC /direct targets Gi protein Metabotropic receptorsMetabotropic receptors Chemogenetics hM4D as a Synaptic Silencer In the presence of the hM4D agonist CNO, the presynaptic AP is still elicited, but postsynaptic currents are inhibited Chemogenetics therapies for epilepsy Focal epilepsy is commonly pharmacoresistant, and resective surgery is often contraindicated by proximity to eloquent cortex. Many patients have no effective treatment options. Tetanus toxin model of chronic epilepsy, which responds poorly to antiepileptic drugs X-genetics • Optogenetics: introduction • Cellular precision • Opsin types • Light delivery systems • Examples of optical interrogation of neural circuits • Other uses of optogenetics • Non-opotogentics - Chemogenetics - Magnetogenetics Magnetogenetics It promises: - Not as invasive as optogenetics - As fast as optogenetics Why magnetic stimulation? Unlike light, magnetic fields penetrate tissue unimpeded, and indeed, magnetic therapies have been used for over 3 decades to remotely stimulate the brain without the need for surgery. Transcranial magnetic stimulation (TMS) is for example used as a treatment for multiple brain disorders, including major depression. rTMS suffers however from technical limitations, including poor spatial resolution, which makes it impossible to target specific neuronal circuits. Molecular targets of magnetogenetics Mechano-sensitive ion channels Mechano-sensitive receptors Integrins Cadherins Fast opening/closing of ion channels Neuron-wide membrane hyper/de-polarization Neuron-wide change in AP firing propensity Prolonged stimulation of mechano-receptors Localized subcellular (synaptic) effects on cytoskeleton Long-term rearrangement neural connectivity How to stimulate mechano-sensitive proteins Ferritin is paramagnetic! All ‘genetic’ approach: ferritin + receptor How to stimulate mechano-sensitive proteins All ‘genetic’ approach: ferritin + receptor ‘Non-genetic’: Magnetic particle + ‘Genetic’: receptor Ferritin is paramagnetic! How to stimulate mechano-sensitive proteins All ‘genetic’ approach: ferritin + receptor ‘Non-genetic’: Magnetic particle (MNP) + ‘Genetic’: receptor Ferritin is paramagnetic! How to stimulate mechano-sensitive proteins All ‘genetic’ approach: ferritin + receptor ‘Non-genetic’: Magnetic nanoparticle (MNP) + ‘Genetic’: receptor Ferritin is paramagnetic! How to stimulate mechano-sensitive proteins How to stimulate mechano-sensitive proteins Magneto-mechano-stimulation in vitro: multi-pole magnetic tweezers Magneto-mechano-stimulation in vivo: repetitive transcranial magnetic stimulation (rTMS) rTMS w/o the ‘genetic’ counterpart is not magneto- genetics rTMS directly evokes APs via electromagnetic induction rTMS is used as a treatment for major depression rTMS has poor spatial resolution (cm3) The rTMS setup could be repurposed to mechanically stimulate MNPs for magnetogenetics Possible molecular targets for magnetogenetics Mechano-sensitive ion channels Integrins Cadherins Fast opening/closing of ion channels Neuron-wide membrane hyper/de-polarization Neuron-wide change in AP firing propensity Prolonged stimulation of mechano-receptors Localized subcellular (synaptic) effects on cytoskeleton Long-term rearrangement neural connectivity Neuron-wide resolution As for optogenetics Synaptic resolution Not possible with optogenetics Mechano-sensitive receptors Synaptic mechanogenetics Synaptic mechanogenetics www.synmech.eu http://www.synmech.eu/ Conclusions - chemogenetics/magnetogenetics 1. Chemogenetics: is less invasive than optogenetics but is slower than optogenetics relies on engineered G-protein coupled receptors (GPCRs): Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) 2. Magneto-genetics: is less invasive than optogenetics is as fast as optogenetics can achieve a subcellular (synaptic) resolution generally needs a ‘genetic’ component (the mechano-sensitive ion channel or receptor) and a ‘non genetic’ component (the magnetic nanoparticle; MNP) can be used in vitro (with magnetic tweezers) and in vivo (with rTMS)